Fri, April 19, 2024
Thu, April 18, 2024
Wed, April 17, 2024

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $54 on, Apr 18th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-54-on-apr-18th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $54 on, Apr 18th, 2024.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $34 on, Friday, March 15th, 2024

Publication Contributing Sources